RNVU1-23

Across TCGA pan-cancer cohorts, RNVU1-23 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNVU1-23 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNVU1-23 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNVU1-23 expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

COAD, THYM, and CESC are the cancer types where RNVU1-23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.660	0.797	.019	38	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	36	view →
CESC	OS	Tertile	III,IV	0.146	0.667	.001	36	view →
STAD	OS	Quartile	II,III,IV	0.332	0.623	.005	28	view →
READ	DFS	Tertile	IV	0.182	0.668	.008	18	view →
OV	OS	Tertile	All	0.615	0.705	.028	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	12	view →
PAAD	DFS	Tertile	II,III,IV	0.234	0.454	.046	9	view →
BRCA	DFS	Tertile	All	1.000	0.899	.046	6	view →
UCEC	OS	Tertile	III,IV	0.707	0.842	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNVU1-23–COAD (OS)

Open the COAD breakdown →